View Older Stories View More Recent Stories

May 4, 2026 04:05PM InspireMD Reports First Quarter 2026 Financial Results
May 1, 2026 04:05PM InspireMD receives FDA approval for pivotal study of neuro protection system
May 1, 2026 04:05PM InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
May 1, 2026 04:05PM InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
Mar 18, 2026 07:00AM InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results
Jan 20, 2026 09:00AM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 21, 2025 09:00AM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 4, 2025 07:00AM InspireMD Reports Third Quarter 2025 Financial Results
Oct 8, 2025 08:00AM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 25, 2025 04:05PM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 17, 2025 08:00AM InspireMD appoints Dan Dearen to board of directors
Sep 17, 2025 08:00AM InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
Aug 5, 2025 08:00AM InspireMD Reports Second Quarter 2025 Financial Results
Jul 31, 2025 08:32AM InspireMD raises $58 million through equity placement and warrant exercise
Jul 31, 2025 08:31AM InspireMD appoints Raymond W. Cohen to board of directors
Jul 31, 2025 08:31AM InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors
Jul 31, 2025 08:30AM InspireMD Announces Combined Financings of $58 Million
Jul 9, 2025 07:01AM InspireMD launches CGuard Prime carotid stent system in US market
Jul 9, 2025 07:00AM InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke
Jun 24, 2025 04:06PM InspireMD (NSPR) Announces FDA Approval for CGuard Prime Carotid Stent System for the Prevention of Stroke
Jun 24, 2025 04:05PM InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
Jun 13, 2025 09:00AM InspireMD (NSPR) Announces CE Mark Approval for CGuard Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
Jun 13, 2025 09:00AM InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
May 9, 2025 07:00AM InspireMD Reports First Quarter 2025 Financial Results
Apr 8, 2025 09:00AM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 12, 2025 07:00AM InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 25, 2025 08:00AM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 13, 2025 07:00AM InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures
Feb 4, 2025 07:00AM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 21, 2025 07:00AM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 12, 2024 07:00AM InspireMD (NSPR) Announces CFO Change
Dec 12, 2024 07:00AM InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
Dec 9, 2024 07:00AM InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)
Nov 25, 2024 04:06PM InspireMD (NSPR)Appoints Scott R. Ward to its Board
Nov 25, 2024 04:05PM InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors
Nov 12, 2024 07:00AM InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 8, 2024 05:30PM InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 15, 2024 07:00AM InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System
Oct 7, 2024 07:04AM InspireMD (NSPR) Announces Approval of IDE Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System
Oct 7, 2024 07:00AM InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System
Sep 16, 2024 07:07AM InspireMD (NSPR) Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
Sep 16, 2024 07:00AM InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
Aug 6, 2024 08:09AM InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update
Aug 5, 2024 07:00AM InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment
Jul 1, 2024 07:00AM InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
May 28, 2024 08:53AM InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024  
May 14, 2024 07:00AM InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
Mar 26, 2024 07:00AM InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
Mar 6, 2024 07:00AM InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Feb 12, 2024 07:00AM InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System
View More Recent Stories View Older Stories